Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Program 3 (Sauvie Inc.)
- Development stage
- Preclinical
- Lead developer
- Sauvie
- Modality
- Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics
01
Overview
Program 3 is a preclinical-stage multi-specific antibody candidate being developed by Sauvie using its proprietary CAM-V™ (Constant domain of Antibody Mimicry and Variation) platform. The therapeutic is designed to engage CD16a (FcγRIIIa), an activating receptor found on immune effector cells such as Natural Killer (NK) cells and macrophages, to trigger immune activation and target lysis. While the primary immune-engaging target is CD16a, the second target (Target 3) remains undisclosed by the company. The program is currently in the mid-discovery phase of preclinical development, intended for the treatment of cancer.
- Other names
- Program 3-Sauvie-CD16a-Target 3 (undisclosed)-CAM-V antibody
02
Targets
FCGR3A (Low affinity immunoglobulin gamma Fc region receptor III-A)
Beyond the preview
Go deeper on Program 3 (Sauvie Inc.).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Program 3 (Sauvie Inc.).